Implementing Treatment Advances in Eosinophilic Esophagitis Care Across All Ages in Rural and Underserved Communities
Released On
August 29, 2025
Expires On
August 29, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Allergy & Immunology, Emergency Medicine, Gastroenterology, Obstetrics & Gynecology, Pediatrics, Pharmacy, Primary Care
Topic(s)
Allergies, Nutrition, Pediatrics
Acknowledgement
This activity is provided by Talem Health and RME Collaborative.
This online program is recorded content from the live session at Rural Health Clinical Congress Spring 2025 and is co-supported by independent medical education grants from AbbVie Inc.; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Merck & Co., Inc., Rahway, NJ, USA; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals, Inc. and Sanofi; and Takeda Pharmaceuticals U.S.A., Inc. This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Contact Hour (0.25 contact hour of pharmacotherapy credit)
- Pharmacists — 1.0 Contact Hour (0.1 CEU)
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed specifically for primary care physicians, nurse practitioners, physician assistants, nurses, and pharmacists who care for patients from rural and underserved communities.
Program Overview
Eosinophilic esophagitis (EoE) is a progressive, inflammatory disease characterized by chronic esophageal dysfunction that can lead to dysphagia and food impaction. Early diagnosis and adequate treatment are crucial to optimize clinical outcomes, yet management can be difficult in rural and underserved communities where specialist access is limited. Increased understanding of the condition and evidence-based treatment options among primary care clinicians is therefore crucial. In this activity, expert faculty will review the symptoms and clinical presentations of EoE and best practices for integrating current and emerging therapies into care based on newly updated guideline recommendations. They will also share collaborative, patient-based strategies to overcome barriers and appropriately support patients with EoE in rural and underserved areas.
This enduring activity is a recorded session from Rural Health Clinical Congress Spring 2025 that took place on May 17, 2025.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the symptoms and clinical presentations of EoE to facilitate the early recognition of patients who require further workup for a definitive diagnosis
- Evaluate the efficacy and safety of current and emerging therapies for EoE
- Apply current guideline recommendations and clinical evidence to improve management of EoE in rural primary care, including appropriate use of new and emerging therapies
- Implement collaborative, patient-centered strategies to appropriately support patients with EoE residing in rural and underserved communities
Faculty
Paul E. Feuerstadt, MD
Associate Clinical Professor of Medicine
Yale University School of Medicine
Managing Partner
PACT Gastroenterology Center
New Haven, CT
Cody A. Chastain, MD, MEHP
Associate Professor of Medicine
Vanderbilt University Medical Center
Nashville, TN
Joint Accreditation Statement
In support of improving patient care, Talem Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
Talem Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.25 contact hour of pharmacotherapy credit for Advanced Practice Registered Nurses.
Continuing Pharmacy Education
Talem Health designates this continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008332-0000-25-058-H01-P)
Type of Activity: Application
Disclosures of Conflicts of Interest
Talem Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All identified conflicts of interest are thoroughly vetted and mitigated according to Talem Health policy. Talem Health is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
All relevant financial relationships have been mitigated.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Faculty
Paul E. Feuerstadt, MD, has disclosed the following relevant financial relationships: consultant/advisory board member for AstraZeneca Pharmaceuticals, Ferring Pharmaceuticals, Inc., Nestlé Health Science, ProbioTech USA, LLC, Regeneron Pharmaceuticals, Inc., Sanofi, and Vedanta Biosciences, Inc.; speakers’ bureau member for Ferring Pharmaceuticals, Inc., Nestlé Health Science, Regeneron Pharmaceuticals, Inc., and Sanofi; grant/research support from Ellodi Pharmaceuticals, Ferring Pharmaceuticals, Inc., and Takeda Pharmaceuticals.
Cody A. Chastain, MD, MEHP, has no relevant financial relationships to disclose.
Planners, Managers, and Reviewer
The Talem Health planners, managers, and reviewer have nothing to disclose.
Instructions for Participation and Credit
This activity is offered at no cost to participants. To receive CME credit, participants must:
- Read the CME/CE information, including learning objectives and disclosure statements.
- Complete the pre-test.
- View the online activity.
- Complete the post-test and evaluation form.
A post-test score of 75% or higher is required to obtain credit. Your certificate will be made available for immediate download.
Course Viewing Requirements
Supported Browsers:
Desktop/laptop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge
Mobile devices: Newest and last prior version of Safari and Google Chrome
Supported Phones & Tablets:
All devices
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
©RME Collaborative, a division of Talem Health, LLC. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.
Media
Internet Activity
Fee Information
There is no fee for this educational activity.
Contact Information
For questions about this activity, please contact RME Collaborative (a division of Talem Health) at 800-913-9370 or [email protected].